 
				
			 
				
			 
				
			 
				
			 
				
			 
				
			Cleerly applies AI and machine learning to coronary computed tomography angiography (CCTA) images to assist clinicians in diagnosing coronary artery disease (CAD). The platform measures stenosis, quantifies plaque volume, and classifies plaque types, offering a comprehensive understanding of a patient’s cardiovascular health. By predicting ischemia risk, Cleerly helps cardiologists develop personalized treatment strategies and track disease progression over time. It enables non-invasive, precise diagnostics and reduces reliance on invasive procedures such as cardiac catheterization. Cleerly’s intuitive dashboards and visualizations simplify interpretation, making it easier for healthcare providers to make data-driven decisions. The platform supports clinical research, preventive care, and patient monitoring, improving outcomes and operational efficiency in cardiology practices.
Key Features
AI analysis of coronary CT angiography (CCTA) images
Plaque volume quantification and classification
Stenosis measurement and ischemia risk prediction
Non-invasive cardiovascular diagnostics
Personalized treatment planning and disease monitoring
Visual dashboards and actionable insights for clinicians
Industries
Healthcare & Cardiology
Hospitals & Clinics
Life Sciences & Research
Preventive Medicine & Diagnostics
Digital Pathology & Medical Imaging